|
|
Last Modified: 10/24/2008 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
0 to 18
|
|
|
|
NCI
|
|
|
|
CCG-3891
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
any age
|
|
|
|
NCI
|
|
|
|
MSKCC-94004 E-2894, NCI-T93-0198D, T93-0198
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 5/1/1996 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 75
|
|
|
|
|
|
|
|
EORTC-30951 NCT00002737
|
|
|
|
|
|
|
|
Last Modified: 5/21/2007  First Published: 10/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
16 and over
|
|
|
|
NCI
|
|
|
|
MDA-DM-97050 NCI-T97-0078, NCT00003564, T97-0078
|
|
|
|
|
|
|
|
Last Modified: 5/21/2007  First Published: 11/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
18 and over
|
|
|
|
NCI
|
|
|
|
MDA-DM-97078 NCI-P98-0132, NCT00003599
|
|
|
|
|
|
|
|
Last Modified: 10/3/2007  First Published: 1/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
30 and under
|
|
|
|
NCI
|
|
|
|
COG-A3973 CCG-A3973, POG-A3973, CCG-39703, FHCRC-1631.00, NCT00004188, A3973
|
|
|
|
|
|
|
|
Last Modified: 1/14/2009  First Published: 11/1/2001 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Temporarily closed
|
|
|
|
30 and under at diagnosis
|
|
|
|
NCI
|
|
|
|
COG-ANBL0032 ANBL0032, COG-P9842, NCT00026312
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
over 18
|
|
|
|
|
|
|
|
UCCRC-3723 ICC-82L4, NCI-V83-0135
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
18 to 80
|
|
|
|
|
|
|
|
MDA-DM-8489 NCI-V85-0151
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Prevention
|
|
|
|
Closed
|
|
|
|
40 to 75
|
|
|
|
|
|
|
|
DCPC-CPSB-10305
|
|
|
|